Literature DB >> 22244832

Hb S-São Paulo: a new sickling hemoglobin with stable polymers and decreased oxygen affinity.

Susan E D C Jorge1, Ariel A Petruk, Elza M Kimura, Denise M Oliveira, Lucas Caire, Cintia N Suemasu, Paulo A A Silveira, Dulcineia M Albuquerque, Fernando F Costa, Munir S Skaf, Leandro Martínez, Maria de Fatima Sonati.   

Abstract

Hb S-São Paulo (SP) [HBB:c.20A>T p.Glu6Val; c.196A>G p.Lys65Glu] is a new double-mutant hemoglobin that was found in heterozygosis in an 18-month-old Brazilian male with moderate anemia. It behaves like Hb S in acid electrophoresis, isoelectric focusing and solubility testing but shows different behavior in alkaline electrophoresis, cation-exchange HPLC and RP-HPLC. The variant is slightly unstable, showed reduced oxygen affinity and also appeared to form polymers more stable than the Hb S. Molecular dynamics simulation suggests that the polymerization is favored by interfacial electrostatic interactions. This provides a plausible explanation for some of the reported experimental observations.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22244832     DOI: 10.1016/j.abb.2012.01.001

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  α-chain hemoglobin variants with electrophoretic mobility similar to that of hemoglobin S in newborn screening programs.

Authors:  Maria de Fátima Sonati
Journal:  Rev Bras Hematol Hemoter       Date:  2013

2.  Alpha chain hemoglobins with electrophoretic mobility similar to that of hemoglobin S in a newborn screening program.

Authors:  Marcilene Rezende Silva; Shimene Mascarenhas Sendin; Isabela Couto de Oliveira Araujo; Fernanda Silva Pimentel; Marcos Borato Viana
Journal:  Rev Bras Hematol Hemoter       Date:  2013

Review 3.  The carrier state for sickle cell disease is not completely harmless.

Authors:  Julia Zhe Xu; Swee Lay Thein
Journal:  Haematologica       Date:  2019-05-16       Impact factor: 9.941

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.